(Q46806360)

25 December 2017

title

Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis (English)

1 reference

25 December 2017

non-alcoholic steatohepatitis

0 references

0 references

1 reference

1 reference

1 reference

1 reference

Claudia Pinto Marques Souza de Oliveira

1

1 reference

25 December 2017

José Tadeu Stefano

2

1 reference

25 December 2017

Erika Rabelo Forte de Siqueira

3

1 reference

25 December 2017

Leonardo Soares Silva

4

1 reference

25 December 2017

Daniel Ferraz de Campos Mazo

5

1 reference

25 December 2017

Vicência Mara Rodrigues Lima

6

1 reference

25 December 2017

Carlos Kioshi Furuya

7

1 reference

25 December 2017

Evandro Sobroza Mello

8

1 reference

25 December 2017

Fabrício G Souza

9

1 reference

25 December 2017

Fabíola Rabello

10

1 reference

25 December 2017

Telma Eugênio Santos

11

1 reference

25 December 2017

Monize Aydar Nogueira

12

1 reference

25 December 2017

Stephen H Caldwell

13

1 reference

25 December 2017

Venâncio Avancini Ferreira Alves

14

1 reference

25 December 2017

Flair José Carrilho

15

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

published in

Hepatology Research

1 reference

25 December 2017

volume

38

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

159-165

1 reference

25 December 2017

Subacute liver failure in obese women

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Impact of steatosis on perioperative outcome following hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Serum leptin levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Revalidation of description of constipation in terms of recall bias and visual scale analog questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00215.X

10.1111/J.1872-034X.2007.00215.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18197877

1 reference

25 December 2017